FDA warns about counterfeit versions of Novo's diabetes drug Ozempic

The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's (NOVOb.CO) diabetes drug Ozempic that have been found in the country's drug supply chain.